Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for St. Charles Hospital located at 200 Belle Terre Rd, Port Jefferson, NY, 11777 & includes data from NPIs 1225097652, 1164481529
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for St. Charles Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 653 | 590 | ||||||||||
Surgical | 164 | 159 | ||||||||||
Non Surgical | 489 | 431 | ||||||||||
Orthopedics | 191 | 185 | ||||||||||
Neurology | 76 | 70 | ||||||||||
General Medicine | 76 | 68 | ||||||||||
Psychiatry & Mental Disorders | 70 | 51 | ||||||||||
Cardiovascular | 58 | 46 | ||||||||||
Pulmonology | 44 | 41 | ||||||||||
Urology | 41 | 38 | ||||||||||
Gastroenterology & Endocrinology | 39 | 37 | ||||||||||
General Surgery | 20 | 19 | ||||||||||
Oncology & Hematology | 13 | 11 |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Rehabilitation |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcohol/Drug Abuse Or Dependence | ||||||||||||
DRG 895: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY | ||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Alcohol/Drug Abuse Or Dependence, Left Ama | ||||||||||||
DRG 894: ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |